logo

AVNS

Avanos Medical·NYSE
--
--(--)
--
--(--)
9.96 / 10
Outperform

AVNS boasts exceptional fundamentals: net profit margin of 106.23% and 100% of profit attributable to shareholders, with a strong interest coverage ratio of 15.48. These metrics place AVNS in top performance groups, contributing to an 'Outperform' fundamental rating. Only revenue-to-market value shows a slight weakness, yet overall financial health is excellent.

Fundamental(9.96)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value0.78
Score1/3
Weight-281.76%
1M Return-1.83%
ROA (%)
Value-6.44
Score1/3
Weight-103.19%
1M Return-0.54%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight-284.67%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight-401.90%
1M Return-2.55%
Cash-UP
Value0.24
Score2/3
Weight-693.98%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-8.59
Score1/3
Weight-103.19%
1M Return-0.54%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-320.94%
1M Return-1.95%
Asset-MV
Value-0.50
Score3/3
Weight709.40%
1M Return3.31%
Cash-MV
Value-0.32
Score3/3
Weight1341.90%
1M Return5.98%
Net profit / Total profit (%)
Value106.23
Score3/3
Weight238.32%
1M Return1.20%
Is AVNS fundamentally strong?
  • AVNS scores 9.96/10 on fundamentals and holds a Discounted valuation at present. Backed by its -8.91% ROE, -67.00% net margin, -1.46 P/E ratio, 0.87 P/B ratio, and -3097.06% earnings growth, these metrics solidify its Outperform investment rating.